IOWA CITY, Iowa, Feb. 22, 2018 /PRNewswire/ — IDx, a privately-held AI diagnostics company, today announced that IDx-DR, an AI-based system for the autonomous detection of diabetic retinopathy, met its endpoints in a pivotal FDA trial involving 900 people with diabetes. IDx-DR was…
